APO Research
Talk to an analyst

APO RESEARCH · REPORT

Prothrombin Complex

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Prothrombin Complex Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

20 December 2025187 pages

Choose your research edition.

Industry ResearchProthrombin Complex Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Prothrombin Complex Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Prothrombin Complex Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Prothrombin Complex Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Prothrombin Complex Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Prothrombin Complex market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Prothrombin Complex is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Prothrombin Complex is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Prothrombin Complex is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Prothrombin Complex is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Prothrombin Complex include Takeda, Hualan Biological, Octapharma, Meheco Xinxing Pharma, Grifols and CSL, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Prothrombin Complex market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Prothrombin Complex and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Prothrombin Complex sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Prothrombin Complex market size, projected growth trends, production technologies, key applications, and end-use industries.

Prothrombin Complex Segment by Company

Takeda

Hualan Biological

Octapharma

Meheco Xinxing Pharma

Grifols

CSL

Prothrombin Complex Segment by Type

500 IU/Vial

600 IU/Vial

1000 IU/Vial

Others

Prothrombin Complex Segment by Application

Hemophilia B

Vitamin K Deficiency

Others

Prothrombin Complex Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prothrombin Complex market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Prothrombin Complex and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prothrombin Complex.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Prothrombin Complex market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Prothrombin Complex manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Prothrombin Complex in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Prothrombin Complex in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Prothrombin Complex Industry Trends Table 2. Prothrombin Complex Industry Drivers Table 3. Prothrombin Complex Industry Opportunities and Challenges Table 4. Prothrombin Complex Industry Restraints Table 5. Global Prothrombin Complex Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Prothrombin Complex Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Prothrombin Complex Sales by Manufacturers (Tons) & (2021-2026) Table 8. Global Prothrombin Complex Sales Market Share by Manufacturers Table 9. Global Prothrombin Complex Average Sales Price (US$/Ton) of Manufacturers (2021-2026) Table 10. Global Prothrombin Complex Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Prothrombin Complex Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Prothrombin Complex Manufacturers, Product Type & Application Table 13. Global Prothrombin Complex Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Prothrombin Complex by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 500 IU/Vial Table 17. Major Manufacturers of 600 IU/Vial Table 18. Major Manufacturers of 1000 IU/Vial Table 19. Major Manufacturers of Others Table 20. Global Prothrombin Complex Sales by Type 2021 VS 2025 VS 2032 (Tons) Table 21. Global Prothrombin Complex Sales by Type (2021-2026) & (Tons) Table 22. Global Prothrombin Complex Sales by Type (2027-2032) & (Tons) Table 23. Global Prothrombin Complex Sales Market Share by Type (2021-2026) Table 24. Global Prothrombin Complex Sales Market Share by Type (2027-2032) Table 25. Global Prothrombin Complex Revenue by Type 2021 VS 2025 VS 2032 (Tons) Table 26. Global Prothrombin Complex Revenue by Type (2021-2026) & (Tons) Table 27. Global Prothrombin Complex Revenue by Type (2027-2032) & (Tons) Table 28. Global Prothrombin Complex Revenue Market Share by Type (2021-2026) Table 29. Global Prothrombin Complex Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Hemophilia B Table 31. Major Manufacturers of Vitamin K Deficiency Table 32. Major Manufacturers of Others Table 33. Global Prothrombin Complex Sales by Application 2021 VS 2025 VS 2032 (Tons) Table 34. Global Prothrombin Complex Sales by Application (2021-2026) & (Tons) Table 35. Global Prothrombin Complex Sales by Application (2027-2032) & (Tons) Table 36. Global Prothrombin Complex Sales Market Share by Application (2021-2026) Table 37. Global Prothrombin Complex Sales Market Share by Application (2027-2032) Table 38. Global Prothrombin Complex Revenue by Application 2021 VS 2025 VS 2032 (Tons) Table 39. Global Prothrombin Complex Revenue by Application (2021-2026) & (Tons) Table 40. Global Prothrombin Complex Revenue by Application (2027-2032) & (Tons) Table 41. Global Prothrombin Complex Revenue Market Share by Application (2021-2026) Table 42. Global Prothrombin Complex Revenue Market Share by Application (2027-2032) Table 43. Global Prothrombin Complex Sales by Region: 2021 VS 2025 VS 2032 (Tons) Table 44. Global Prothrombin Complex Sales by Region (2021-2026) & (Tons) Table 45. Global Prothrombin Complex Sales Market Share by Region (2021-2026) Table 46. Global Prothrombin Complex Sales Forecasted by Region (2027-2032) & (Tons) Table 47. Global Prothrombin Complex Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Prothrombin Complex Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 49. North America Prothrombin Complex Sales by Country (2021-2026) & (Tons) Table 50. North America Prothrombin Complex Sales by Country (2027-2032) & (Tons) Table 51. Europe Prothrombin Complex Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 52. Europe Prothrombin Complex Sales by Country (2021-2026) & (Tons) Table 53. Europe Prothrombin Complex Sales by Country (2027-2032) & (Tons) Table 54. Asia Pacific Prothrombin Complex Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 55. Asia Pacific Prothrombin Complex Sales by Country (2021-2026) & (Tons) Table 56. Asia Pacific Prothrombin Complex Sales by Country (2027-2032) & (Tons) Table 57. South America, Middle East and Africa Prothrombin Complex Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 58. South America, Middle East and Africa Prothrombin Complex Sales by Country (2021-2026) & (Tons) Table 59. South America, Middle East and Africa Prothrombin Complex Sales by Country (2027-2032) & (Tons) Table 60. Global Prothrombin Complex Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Prothrombin Complex Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Prothrombin Complex Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Prothrombin Complex Revenue Market Share by Region (2021-2026) Table 64. Global Prothrombin Complex Revenue Market Share by Region (2027-2032) Table 65. Takeda Company Information Table 66. Takeda Business Overview Table 67. Takeda Prothrombin Complex Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Takeda Prothrombin Complex Product Portfolio Table 69. Takeda Recent Development Table 70. Hualan Biological Company Information Table 71. Hualan Biological Business Overview Table 72. Hualan Biological Prothrombin Complex Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Hualan Biological Prothrombin Complex Product Portfolio Table 74. Hualan Biological Recent Development Table 75. Octapharma Company Information Table 76. Octapharma Business Overview Table 77. Octapharma Prothrombin Complex Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Octapharma Prothrombin Complex Product Portfolio Table 79. Octapharma Recent Development Table 80. Meheco Xinxing Pharma Company Information Table 81. Meheco Xinxing Pharma Business Overview Table 82. Meheco Xinxing Pharma Prothrombin Complex Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Meheco Xinxing Pharma Prothrombin Complex Product Portfolio Table 84. Meheco Xinxing Pharma Recent Development Table 85. Grifols Company Information Table 86. Grifols Business Overview Table 87. Grifols Prothrombin Complex Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Grifols Prothrombin Complex Product Portfolio Table 89. Grifols Recent Development Table 90. CSL Company Information Table 91. CSL Business Overview Table 92. CSL Prothrombin Complex Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. CSL Prothrombin Complex Product Portfolio Table 94. CSL Recent Development Table 95. Key Raw Materials Table 96. Raw Materials Key Suppliers Table 97. Prothrombin Complex Distributors List Table 98. Prothrombin Complex Customers List Table 99. Research Programs/Design for This Report Table 100. Authors List of This Report Table 101. Secondary Sources Table 102. Primary Sources List of Figures Figure 1. Prothrombin Complex Product Image Figure 2. Global Prothrombin Complex Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Prothrombin Complex Market Size (2021-2032) & (US$ Million) Figure 4. Global Prothrombin Complex Sales (2021-2032) & (Tons) Figure 5. Global Prothrombin Complex Average Price (US$/Ton) & (2021-2032) Figure 6. Global Top 5 and 10 Prothrombin Complex Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 500 IU/Vial Image Figure 9. 600 IU/Vial Image Figure 10. 1000 IU/Vial Image Figure 11. Others Image Figure 12. Global Prothrombin Complex Sales by Type (2021 VS 2025 VS 2032) & (Tons) Figure 13. Global Prothrombin Complex Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Prothrombin Complex Sales Market Share by Type (2021-2032) Figure 15. Global Prothrombin Complex Revenue by Type (2021 VS 2025 VS 2032) & (Tons) Figure 16. Global Prothrombin Complex Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Prothrombin Complex Revenue Market Share by Type (2021-2032) Figure 18. Hemophilia B Image Figure 19. Vitamin K Deficiency Image Figure 20. Others Image Figure 21. Global Prothrombin Complex Sales by Application (2021 VS 2025 VS 2032) & (Tons) Figure 22. Global Prothrombin Complex Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Prothrombin Complex Sales Market Share by Application (2021-2032) Figure 24. Global Prothrombin Complex Revenue by Application (2021 VS 2025 VS 2032) & (Tons) Figure 25. Global Prothrombin Complex Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Prothrombin Complex Revenue Market Share by Application (2021-2032) Figure 27. North America Prothrombin Complex Sales and Growth Rate (2021-2032) & (Tons) Figure 28. North America Prothrombin Complex Sales Market Share by Country (2021-2032) Figure 29. U.S. Prothrombin Complex Sales and Growth Rate (2021-2032) & (Tons) Figure 30. Canada Prothrombin Complex Sales and Growth Rate (2021-2032) & (Tons) Figure 31. Mexico Prothrombin Complex Sales and Growth Rate (2021-2032) & (Tons) Figure 32. Europe Prothrombin Complex Sales and Growth Rate (2021-2032) & (Tons) Figure 33. Europe Prothrombin Complex Sales Market Share by Country (2021-2032) Figure 34. Germany Prothrombin Complex Sales and Growth Rate (2021-2032) & (Tons) Figure 35. France Prothrombin Complex Sales and Growth Rate (2021-2032) & (Tons) Figure 36. U.K. Prothrombin Complex Sales and Growth Rate (2021-2032) & (Tons) Figure 37. Italy Prothrombin Complex Sales and Growth Rate (2021-2032) & (Tons) Figure 38. Netherlands Prothrombin Complex Sales and Growth Rate (2021-2032) & (Tons) Figure 39. Asia Pacific Prothrombin Complex Sales and Growth Rate (2021-2032) & (Tons) Figure 40. Asia Pacific Prothrombin Complex Sales Market Share by Country (2021-2032) Figure 41. China Prothrombin Complex Sales and Growth Rate (2021-2032) & (Tons) Figure 42. Japan Prothrombin Complex Sales and Growth Rate (2021-2032) & (Tons) Figure 43. South Korea Prothrombin Complex Sales and Growth Rate (2021-2032) & (Tons) Figure 44. Southeast Asia Prothrombin Complex Sales and Growth Rate (2021-2032) & (Tons) Figure 45. India Prothrombin Complex Sales and Growth Rate (2021-2032) & (Tons) Figure 46. Australia Prothrombin Complex Sales and Growth Rate (2021-2032) & (Tons) Figure 47. South America, Middle East and Africa Prothrombin Complex Sales and Growth Rate (2021-2032) & (Tons) Figure 48. South America, Middle East and Africa Prothrombin Complex Sales Market Share by Country (2021-2032) Figure 49. Brazil Prothrombin Complex Sales and Growth Rate (2021-2032) & (Tons) Figure 50. South Africa Prothrombin Complex Sales and Growth Rate (2021-2032) & (Tons) Figure 51. Saudi Arabia Prothrombin Complex Sales and Growth Rate (2021-2032) & (Tons) Figure 52. Turkey Prothrombin Complex Sales and Growth Rate (2021-2032) & (Tons) Figure 53. Argentina Prothrombin Complex Sales and Growth Rate (2021-2032) & (Tons) Figure 54. UAE Prothrombin Complex Sales and Growth Rate (2021-2032) & (Tons) Figure 55. Egypt Prothrombin Complex Sales and Growth Rate (2021-2032) & (Tons) Figure 56. Chile Prothrombin Complex Sales and Growth Rate (2021-2032) & (Tons) Figure 57. Global Prothrombin Complex Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Prothrombin Complex Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Prothrombin Complex Revenue (2021-2032) & (US$ Million) Figure 60. North America Prothrombin Complex Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Prothrombin Complex Revenue (2021-2032) & (US$ Million) Figure 62. Europe Prothrombin Complex Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Prothrombin Complex Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Prothrombin Complex Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Prothrombin Complex Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Prothrombin Complex Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Prothrombin Complex Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Prothrombin Complex Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • 500 IU/Vial
  • 600 IU/Vial
  • 1000 IU/Vial
  • Others
Applications
  • Hemophilia B
  • Vitamin K Deficiency
  • Others
Companies covered
  • Takeda
  • Hualan Biological
  • Octapharma
  • Meheco Xinxing Pharma
  • Grifols
  • CSL

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Prothrombin Complex Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Prothrombin Complex Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Prothrombin Complex Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Prothrombin Complex Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Prothrombin Complex Market Dynamics
  1. 2.1 Prothrombin Complex Industry Trends
  2. 2.2 Prothrombin Complex Industry Drivers
  3. 2.3 Prothrombin Complex Industry Opportunities and Challenges
  4. 2.4 Prothrombin Complex Industry Restraints
3 Prothrombin Complex Market by Manufacturers
  1. 3.1 Global Prothrombin Complex Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Prothrombin Complex Sales by Manufacturers (2021-2026)
  3. 3.3 Global Prothrombin Complex Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Prothrombin Complex Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Prothrombin Complex Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Prothrombin Complex Manufacturers, Product Type & Application
  7. 3.7 Global Prothrombin Complex Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Prothrombin Complex Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Prothrombin Complex Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Prothrombin Complex Tier 1, Tier 2, and Tier 3
4 Prothrombin Complex Market by Type
  1. 4.1 Prothrombin Complex Type Introduction
  2. 4.1.1 500 IU/Vial
  3. 4.1.2 600 IU/Vial
  4. 4.1.3 1000 IU/Vial
  5. 4.1.4 Others
  6. 4.2 Global Prothrombin Complex Sales by Type
  7. 4.2.1 Global Prothrombin Complex Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Prothrombin Complex Sales by Type (2021-2032)
  9. 4.2.3 Global Prothrombin Complex Sales Market Share by Type (2021-2032)
  10. 4.3 Global Prothrombin Complex Revenue by Type
  11. 4.3.1 Global Prothrombin Complex Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Prothrombin Complex Revenue by Type (2021-2032)
  13. 4.3.3 Global Prothrombin Complex Revenue Market Share by Type (2021-2032)
5 Prothrombin Complex Market by Application
  1. 5.1 Prothrombin Complex Application Introduction
  2. 5.1.1 Hemophilia B
  3. 5.1.2 Vitamin K Deficiency
  4. 5.1.3 Others
  5. 5.2 Global Prothrombin Complex Sales by Application
  6. 5.2.1 Global Prothrombin Complex Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Prothrombin Complex Sales by Application (2021-2032)
  8. 5.2.3 Global Prothrombin Complex Sales Market Share by Application (2021-2032)
  9. 5.3 Global Prothrombin Complex Revenue by Application
  10. 5.3.1 Global Prothrombin Complex Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Prothrombin Complex Revenue by Application (2021-2032)
  12. 5.3.3 Global Prothrombin Complex Revenue Market Share by Application (2021-2032)
6 Global Prothrombin Complex Sales by Region
  1. 6.1 Global Prothrombin Complex Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Prothrombin Complex Sales by Region (2021-2032)
  3. 6.2.1 Global Prothrombin Complex Sales by Region (2021-2026)
  4. 6.2.2 Global Prothrombin Complex Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Prothrombin Complex Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Prothrombin Complex Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Prothrombin Complex Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Prothrombin Complex Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Prothrombin Complex Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Prothrombin Complex Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Prothrombin Complex Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Prothrombin Complex Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Prothrombin Complex Revenue by Region
  1. 7.1 Global Prothrombin Complex Revenue by Region
  2. 7.1.1 Global Prothrombin Complex Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Prothrombin Complex Revenue by Region (2021-2026)
  4. 7.1.3 Global Prothrombin Complex Revenue by Region (2027-2032)
  5. 7.1.4 Global Prothrombin Complex Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Prothrombin Complex Revenue (2021-2032)
  8. 7.2.2 North America Prothrombin Complex Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Prothrombin Complex Revenue (2021-2032)
  11. 7.3.2 Europe Prothrombin Complex Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Prothrombin Complex Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Prothrombin Complex Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Prothrombin Complex Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Prothrombin Complex Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Takeda
  2. 8.1.1 Takeda Company Information
  3. 8.1.2 Takeda Business Overview
  4. 8.1.3 Takeda Prothrombin Complex Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Takeda Prothrombin Complex Product Portfolio
  6. 8.1.5 Takeda Recent Developments
  7. 8.2 Hualan Biological
  8. 8.2.1 Hualan Biological Company Information
  9. 8.2.2 Hualan Biological Business Overview
  10. 8.2.3 Hualan Biological Prothrombin Complex Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Hualan Biological Prothrombin Complex Product Portfolio
  12. 8.2.5 Hualan Biological Recent Developments
  13. 8.3 Octapharma
  14. 8.3.1 Octapharma Company Information
  15. 8.3.2 Octapharma Business Overview
  16. 8.3.3 Octapharma Prothrombin Complex Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Octapharma Prothrombin Complex Product Portfolio
  18. 8.3.5 Octapharma Recent Developments
  19. 8.4 Meheco Xinxing Pharma
  20. 8.4.1 Meheco Xinxing Pharma Company Information
  21. 8.4.2 Meheco Xinxing Pharma Business Overview
  22. 8.4.3 Meheco Xinxing Pharma Prothrombin Complex Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Meheco Xinxing Pharma Prothrombin Complex Product Portfolio
  24. 8.4.5 Meheco Xinxing Pharma Recent Developments
  25. 8.5 Grifols
  26. 8.5.1 Grifols Company Information
  27. 8.5.2 Grifols Business Overview
  28. 8.5.3 Grifols Prothrombin Complex Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Grifols Prothrombin Complex Product Portfolio
  30. 8.5.5 Grifols Recent Developments
  31. 8.6 CSL
  32. 8.6.1 CSL Company Information
  33. 8.6.2 CSL Business Overview
  34. 8.6.3 CSL Prothrombin Complex Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 CSL Prothrombin Complex Product Portfolio
  36. 8.6.5 CSL Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Prothrombin Complex Value Chain Analysis
  2. 9.1.1 Prothrombin Complex Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Prothrombin Complex Production Mode & Process
  6. 9.2 Prothrombin Complex Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Prothrombin Complex Distributors
  9. 9.2.3 Prothrombin Complex Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst